-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JbaffWx2TwmXM+XiKsHeDNS53gY6wB0GYBGCMfR633L3geELYfAcf+sXdnnUlPSx EZLqJsgA6ef67zJmgkH9vQ== 0001104659-07-040561.txt : 20070516 0001104659-07-040561.hdr.sgml : 20070516 20070516151300 ACCESSION NUMBER: 0001104659-07-040561 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20070226 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070516 DATE AS OF CHANGE: 20070516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 3M CO CENTRAL INDEX KEY: 0000066740 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 410417775 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03285 FILM NUMBER: 07857554 BUSINESS ADDRESS: STREET 1: 3M CENTER STREET 2: BLDG. 220-11W-02 CITY: ST PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 6517332204 MAIL ADDRESS: STREET 1: 3M CENTER STREET 2: BLDG. 220-11W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: MINNESOTA MINING & MANUFACTURING CO DATE OF NAME CHANGE: 19920703 8-K 1 a07-9829_18k.htm 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): February 26, 2007

3M COMPANY

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

 

File No. 1-3285

 

41-0417775

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

3M Center, St. Paul, Minnesota

 

55144-1000

(Address of Principal Executive Offices)

 

(Zip Code)

 

 

 

 

(651) 733-1110

(Registrant’s Telephone Number, Including Area Code)

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



Item 8.01. Other Events.

Attached as Exhibit 100 to this report are the following financial statements from 3M Company’s Annual Report on Form 10-K for the year ended December 31, 2006, filed with the Securities and Exchange Commission on February 26, 2007, formatted in XBRL (Extensible Business Reporting Language):  (i) the Consolidated Statement of Income for the years ended December 31, 2006, 2005 and 2004, (ii) the Consolidated Balance Sheet at December 31, 2006 and 2005, (iii) the Consolidated Statement of Changes in Stockholders’ Equity and Comprehensive Income for the years ended December 31, 2006, 2005 and 2004, and (iv) the Consolidated Statements of Cash Flows for the years ended December 31, 2006, 2005 and 2004. Users of this data are advised pursuant to Rule 401 of Regulation S-T that the financial and other information contained in the XBRL documents is unaudited and that these are not the official publicly filed financial statements of 3M Company.  The purpose of submitting these XBRL formatted documents is to test the related format and technology and, as a result, investors should continue to rely on the official filed version of the furnished documents and not rely on the information in this Current Report on Form 8-K, including Exhibit 100, in making investment decisions.

In accordance with Rule 402 of Regulation S-T, the information in this Current Report on Form 8-K, including Exhibit 100, shall not be deemed to be “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibit Number

 

Description

 

 

 

100

 

The following financial statements from 3M Company’s Annual Report on Form 10-K for the year ended December 31, 2006, filed on February 26, 2007, formatted in XBRL: (i) the Consolidated Statement of Income for the years ended December 31, 2006, 2005 and 2004, (ii) the Consolidated Balance Sheet at December 31, 2006 and 2005, (iii) the Consolidated Statement of Changes in Stockholders’ Equity and Comprehensive Income for the years ended December 31, 2006, 2005 and 2004, and (iv) the Consolidated Statements of Cash Flows for the years ended December 31, 2006, 2005 and 2004.

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

3M COMPANY

 

 

 

 

 

 

 

By:

 

/s/ Gregg M. Larson

 

 

 

 

Gregg M. Larson,

 

 

 

 

Associate General Counsel and Secretary

 

 

 

 

 

Dated: May 16, 2007

 

 

 

 

 

 

 

 

 

 

 

2



EXHIBIT INDEX

 

Exhibit Number

 

Description

 

 

 

100

 

The following financial statements from 3M Company’s Annual Report on Form 10-K for the year ended December 31, 2006, filed on February 26, 2007, formatted in XBRL: (i) the Consolidated Statement of Income for the years ended December 31, 2006, 2005 and 2004, (ii) the Consolidated Balance Sheet at December 31, 2006 and 2005, (iii) the Consolidated Statement of Changes in Stockholders’ Equity and Comprehensive Income for the years ended December 31, 2006, 2005 and 2004, and (iv) the Consolidated Statements of Cash Flows for the years ended December 31, 2006, 2005 and 2004.

 

 

3


 EX-100.INS 2 mmm-20061231.xml EX-100.INS 0000066740 2006-12-31 0000066740 2006-01-01 2006-12-31 0000066740 2005-12-31 0000066740 2005-01-01 2005-12-31 0000066740 2004-12-31 0000066740 2004-01-01 2004-12-31 0000066740 2003-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares 1.84 2493000000 1447000000 471000000 3173000000 3102000000 1235000000 795000000 571000000 2601000000 1325000000 8946000000 166000000 314000000 17017000000 11110000000 5907000000 4082000000 708000000 395000000 2506000000 1402000000 520000000 1134000000 1761000000 7323000000 1047000000 0.01 754538387 0.01 734362802 17933000000 8456000000 138000000 -1873000000 9959000000 9000000 21294000000 71000000 776000000 21294000000 2965000000 11335000000 2484000000 4307000000 59000000 1376000000 -257000000 11000000 -2332000000 31200000 841000000 40000000 584000000 -1000000 -56000000 506000000 7000000 -1918000000 259000000 22923000000 11713000000 5066000000 1522000000 -1074000000 17227000000 5696000000 122000000 51000000 -71000000 5625000000 1723000000 51000000 3851000000 3851000000 747500000 5.15 5.15 761000000 5.06 5.06 1079000000 -385000000 440000000 200000000 -316000000 -60000000 -103000000 -309000000 68000000 138000000 58000000 252000000 3839000000 -1168000000 49000000 -888000000 -3253000000 2287000000 304000000 1209000000 -1460000000 882000000 -440000000 693000000 -2351000000 523000000 -1376000000 -38000000 60000000 -14000000 -2061000000 57000000 375000000 -1074000000 1.68 2234000000 1072000000 2911000000 73000000 2838000000 1050000000 706000000 406000000 2162000000 1043000000 7115000000 272000000 16127000000 10534000000 5593000000 3530000000 486000000 2905000000 640000000 20541000000 1072000000 1256000000 469000000 989000000 1452000000 5238000000 1309000000 3599000000 10146000000 9000000 2225000000 15715000000 6965000000 178000000 -411000000 10395000000 20541000000 -578000000 -46000000 1000000 80000000 207000000 1286000000 -308000000 11700000 -2377000000 30700000 915000000 2568000000 18000000 607000000 52000000 21167000000 10408000000 4631000000 1274000000 16313000000 4854000000 82000000 56000000 -26000000 4828000000 1627000000 55000000 3146000000 -35000000 3111000000 764900000 4.11 -0.04 4.07 781300000 4.03 -0.05 3.98 986000000 -788000000 437000000 155000000 132000000 -54000000 -184000000 -294000000 113000000 270000000 122000000 198000000 4204000000 -943000000 41000000 -1293000000 -1627000000 1573000000 8000000 -2241000000 -258000000 -656000000 429000000 -2377000000 545000000 -1286000000 -56000000 54000000 -20000000 -3625000000 -23000000 -1685000000 1.44 10658000000 2027000000 14198000000 5503000000 196000000 132000000 2757000000 490000000 1193000000 3000000 4527000000 1125000000 30000000 306000000 54000000 -1791000000 22000000 -314000000 10900000 886000000 43000000 500000 572000000 20011000000 10002000000 4437000000 1246000000 15685000000 4326000000 69000000 46000000 -23000000 4303000000 1400000000 62000000 2841000000 2841000000 780500000 3.64 3.64 797300000 3.56 3.56 999000000 -759000000 435000000 252000000 243000000 -54000000 56000000 7000000 35000000 83000000 12000000 78000000 4228000000 -937000000 69000000 -73000000 -10000000 13000000 -938000000 399000000 -868000000 358000000 -1791000000 508000000 -1125000000 -11000000 54000000 -4000000 -2480000000 111000000 921000000 8096000000 -1554000000 1721000000 12796000000 4641000000 226000000 1836000000 Activities that represent increases in cash flow are shown as a positive number, while activities that represent decreases in cash flow are shown as a negative number. EX-100.SCH 3 mmm-20061231.xsd EX-100.SCH EX-100.CAL 4 mmm-20061231_cal.xml EX-100.CAL EX-100.LAB 5 mmm-20061231_lab.xml EX-100.LAB Other - Net TreasuryStockIssuancesShares Stock Based Compensation Additional Paid In Capital Tax Effect Changes in assets and liabilities Product Other Insurance Receivables and Claims TreasuryStockIssuancesValue Operating expenses Issuances pursuant to stock option and benefit plans Stock Based Compensation Compensation Cost TotalComprehensiveIncome Company pension and postretirement contributions Consolidated Statement of Income Adjustment to initially apply SFAS No. 158 Excess tax benefits stock based compensation TaxBenefitExerciseStockOptions Amortization of unearned compensation Research, development and related expenses Consolidated Balance Sheet Purchase of marketable securities and investments Proceeds from sale of marketable securities and investments Issuances pursuant to acquisitions Proceeds from sale of pharmaceuticals business Raw materials and supplies Company pension and postretirement expense Consolidated Statement of Changes in Stockholders? Equity and Comprehensive Income Stock Based Compensation Additional Paid In Capital Net Tax Effect Gain on sale of pharmaceuticals business Purchases of property, plant and equipment (PP&E) Stock-based compensation expense Short-term borrowings and current portion of long-term debt Allowance for Accounts Receivable Prepaid pension and postretirement benefits Stock-based compensation Product and other insurance receivables and claims Common Stock and Additional Paid in Capital Change in short-term debt ? net Excess tax benefits from stock-based compensation Consolidated Statement of Cash Flows Derivative financial instruments ? unrealized gain Total Dividends paid EX-100.PRE 6 mmm-20061231_pre.xml EX-100.PRE -----END PRIVACY-ENHANCED MESSAGE-----